Page last updated: 2024-08-26

cobalt and Encephalopathy, Toxic

cobalt has been researched along with Encephalopathy, Toxic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aschner, M; Chen, J; Jin, Y; Li, H; Li, J; Luo, Z; Wu, S; Yang, H; Zeng, J; Zhang, Q; Zheng, C; Zheng, F1
Apostoli, P; Catalani, S; Padovani, A; Rizzetti, MC1
Chamorro, ME; Nesse, AB; Vittori, DC; Wenker, SD1
Bloomquist, JR; Klorig, DC; Kou, J1
Choi, D; Harris, RH; Kohn, H; Kupferberg, HJ; Stables, JP; Stöhr, T; Walton, N; White, HS1

Reviews

1 review(s) available for cobalt and Encephalopathy, Toxic

ArticleYear
Neurotoxicity of cobalt.
    Human & experimental toxicology, 2012, Volume: 31, Issue:5

    Topics: Cobalt; Humans; Neurotoxicity Syndromes; Occupational Exposure; Prostheses and Implants

2012

Other Studies

4 other study(ies) available for cobalt and Encephalopathy, Toxic

ArticleYear
Comparison of the neurotoxicity associated with cobalt nanoparticles and cobalt chloride in Wistar rats.
    Toxicology and applied pharmacology, 2019, 04-15, Volume: 369

    Topics: Animals; Apoptosis; Biomarkers; Brain; Caspase 9; Cobalt; Heme Oxygenase (Decyclizing); Lipid Peroxidation; Male; Malondialdehyde; Metal Nanoparticles; Neurons; Neurotoxicity Syndromes; NF-E2 Transcription Factor, p45 Subunit; PC12 Cells; Rats; Rats, Wistar; Risk Assessment; Tissue Distribution

2019
Protective action of erythropoietin on neuronal damage induced by activated microglia.
    The FEBS journal, 2013, Volume: 280, Issue:7

    Topics: Animals; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Cobalt; Culture Media, Conditioned; Erythropoietin; Humans; Inflammation; Mice; Microglia; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Nitrites; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Receptors, Erythropoietin; Tumor Necrosis Factor-alpha

2013
Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo.
    Neurotoxicology, 2006, Volume: 27, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Blotting, Western; Calcium; Cobalt; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electron Transport Complex I; Glyburide; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Neurotoxicity Syndromes; Potassium Channel Blockers; Rotenone; Tyrosine 3-Monooxygenase

2006
Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Epilepsy research, 2007, Volume: 74, Issue:2-3

    Topics: Acetamides; Animals; Anticonvulsants; Bicuculline; Cobalt; Convulsants; Electroshock; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epilepsy, Reflex; Excitatory Amino Acid Agonists; GABA Antagonists; Homocysteine; Kindling, Neurologic; Lacosamide; Male; Mice; N-Methylaspartate; Neurotoxicity Syndromes; Pentylenetetrazole; Picrotoxin; Rats; Rats, Sprague-Dawley; Status Epilepticus

2007